Detection of abnormal lymphocytes in the peripheral blood of COVID-19 cancer patients: diagnostic and prognostic possibility

References

• Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020;92(4):401–402.
   PubMed Web of Science ®Google Scholar
• John Hopkins University. Coronavirus resource center; 2021. Available from: https://coronavirus.jhu.edu/
   Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Bloomgarden ZT. Diabetes and COVID-19. J Diabetes. 2020;12(4):347–348.
   PubMed Web of Science ®Google Scholar
• Zheng YY, Ma YT, Zhang JY, et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259–260.
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547.
   PubMed Web of Science ®Google Scholar
• Miyashita H, Mikami T, Chopra N, et al. Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann Oncol. 2020;31(8):1088–1089.
   PubMed Web of Science ®Google Scholar
• He W, Chen L, Chen L, et al. COVID-19 in persons with haematological cancers. Leukemia. 2020;34:1637–1645.
   PubMed Web of Science ®Google Scholar
• Lee LY, Cazier JB, Angelis V, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919–1926.
   PubMed Web of Science ®Google Scholar
• Mehta V, Goel S, Kabarriti R, et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020;10(7):935–941.
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020;58(7):1131–1134.
   PubMed Web of Science ®Google Scholar
• Zhang D, Guo R, Lei L, et al. Frontline science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. J Leukoc Biol. 2021;109(1):13–22.
   PubMed Web of Science ®Google Scholar
• Nazarullah A, Liang C, Villarreal A, et al. Peripheral blood examination findings in SARS-CoV-2 infection. Am J Clin Pathol. 2020;154(3):319–329.
   PubMed Web of Science ®Google Scholar
• Kaur G, Sandeep F, Olayinka O, et al. Morphologic changes in circulating blood cells of COVID-19 patients. Cureus. 2021;13(2):e13416.
   PubMed Web of Science ®Google Scholar
• Merino A, Vlagea A, Molina A, et al. Atypical lymphoid cells circulating in blood in COVID-19 infection: morphology, immunophenotype and prognosis value. J Clin Pathol. 2020;75(2):104–111.
   PubMed Web of Science ®Google Scholar
• Pezeshki A, Vaezi A, Nematollahi P. Blood cell morphology and COVID-19 clinical course, severity, and outcome. J Hematop. 2021;14(3):221–228.
   PubMed Web of Science ®Google Scholar
• Merino A, Vlagea A, Molina A, et al. J Clin Pathol. 2022;75:104–111.
   PubMed Web of Science ®Google Scholar
• Pozdnyakova O, Connell NT, Battinelli EM, et al. Clinical significance of CBC and WBC morphology in the diagnosis and clinical course of COVID-19 infection. Am J Clin Pathol. 2021;155(3):364–375.
   PubMed Web of Science ®Google Scholar
• Bahadur S, Kalonia T, Kamini K, et al. Changes in peripheral blood in SARS CoV-2 patients and its clinico-pathological correlation: a prospective cross-sectional study. Int J Lab Hematol. 2021;43(6):1334–1340.
   PubMed Web of Science ®Google Scholar
• Rüthrich MM, Giessen-Jung C, Borgmann S, et al. COVID-19 in cancer patients: clinical characteristics and outcome – an analysis of the LEOSS registry. Ann Hematol. 2021;100(2):383–393.
   PubMed Web of Science ®Google Scholar
• ElGohary GM, Hashmi S, Styczynski J, et al. The risk and prognosis of COVID-19 infection in cancer patients: a systematic review and meta-analysis. Hematol Oncol Stem Cell Ther. 2020;30:S1658-3876(20)30122-9.
   Google Scholar
• World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 2020 Mar 13 (No. WHO/2019-nCoV/clinical/2020.4). World Health Organization; 2020.
   Google Scholar
• Madhusoodhan PP, Pierro J, Musante J, et al. Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience. Pediatr Blood Cancer. 2021;68(3):e28843.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected: interim guidance (No. WHO/MERS/Clinical/15.1 Revision 1). World Health Organization; 2019.
   Google Scholar
• Leach M, Bain BJ. Haematology: from the image to the diagnosis. NK/T-cell lymphoma in leukaemic phase. 1st ed. Hoboken, NJ: John Wiley & Sons; 2022.
   Google Scholar
• Zambello R, Semenzato G. Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches. Haematologica. 2009;94(10):1341–1345.
   PubMed Web of Science ®Google Scholar
• Foldes D, Hinton R, Arami S, et al. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19). Am J Hematol. 2020;95(7):861–862. DOI:10.1002/ajh.25834.
   PubMed Web of Science ®Google Scholar
• Wang F, Nie J, Wang H, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis. 2020;221(11):1762–1769.
   PubMed Web of Science ®Google Scholar
• Gérard D, Henry S, Thomas B. SARS-CoV-2: a new aetiology for atypical lymphocytes. Br J Haematol. 2020;189(5):845.
   PubMed Web of Science ®Google Scholar
• Weinberg SE, Behdad A, Ji P. Atypical lymphocytes in peripheral blood of patients with COVID-19. Br J Haematol. 2020;190(1):36–39.
   PubMed Web of Science ®Google Scholar
• Chong VCL, Lim KGE, Fan BE, et al. Reactive lymphocytes in patients with Covid-19. Br J Haematol. 2020. DOI:10.1111/bjh.16690.
   Google Scholar
• El Jamal SM, Salib C, Stock A, et al. Atypical lymphocyte morphology in SARS-CoV-2 infection. Pathol Res Pract. 2020;216(9):153063.
   PubMed Web of Science ®Google Scholar
• Zini G, Bellesi S, Ramundo F, et al. Morphological anomalies of circulating blood cells in COVID-19. Am J Hematol. 2020;95(7):870–872.
   PubMed Web of Science ®Google Scholar
• Singh A, Sood N, Narang V, et al. Morphology of COVID-19-affected cells in peripheral blood film. BMJ Case Rep. 2020;13(5):e236117.
   PubMedGoogle Scholar
• Mitra A, Dwyre DM, Schivo M, et al. Leukoerythroblastic reaction in a patient with COVID-19 infection. Am J Hematol. 2020;95(8):999–1000.
   PubMed Web of Science ®Google Scholar
• Sadigh S, Massoth LR, Christensen BB, et al. Peripheral blood morphologic findings in patients with COVID-19. Int J Lab Hematol. 2020;42(6):e248–e251.
   PubMed Web of Science ®Google Scholar
• Ahnach M, Ousti F, Nejjari S, et al. Peripheral blood smear findings in COVID-19. Turk J Haematol. 2020;37(4):310–302.
   PubMed Web of Science ®Google Scholar
• Lefrançais E, Ortiz-Muñoz G, Caudrillier A, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 2017;544(7648):105–109.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–848.
   PubMed Web of Science ®Google Scholar
• Sun S, Cai X, Wang H, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta. 2020;507:174–180.
   PubMed Web of Science ®Google Scholar
• Qian GQ, Yang NB, Ding F, et al. Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series. QJM. 2020;113(7):474–481.
   PubMed Web of Science ®Google Scholar
• Mo P, Xing Y, Xiao Y, et al. Clinical characteristics of refractory Coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2021;73(11):e4208–e4213.
   PubMed Web of Science ®Google Scholar
• Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834–847.
   PubMed Web of Science ®Google Scholar
• Joharatnam-Hogan N, Khan K. COVID-19 cancer conundrum – evidence driving decisions or the lack of it? BMC Med. 2020;18(1):182.
   PubMed Web of Science ®Google Scholar
• Nooh HA, Abdellateif MS, Refaat L, et al. The role of inflammatory indices in the outcome of COVID-19 cancer patients. Med Oncol. 2022;39(1):6.
   Web of Science ®Google Scholar
• Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894–901.
   PubMed Web of Science ®Google Scholar
• Liu YP, Liu Y, Huang QC, et al. Morphological changes of lymphocytes in peripheral blood smears of patients with COVID-19. Ann Palliat Med. 2020;9(6):4420–4422.
   PubMed Web of Science ®Google Scholar